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Nuclear magnetic resonanceFAAP20 (Fanconi anemia-associated protein 20) is a subunit of the Fanconi anemia (FA) core
complex that repairs interstrand cross-links. To understand the molecular basis for the FA core
complex-mediated recruitment of Rev1 to the DNA lesion, we characterized the interactions among
FAAP20-UBZ4, Rev1-BRCT, and ubiquitin using NMR. We found that FAAP20-UBZ4 binds not
only ubiquitin but also Rev1-BRCT. Mapping the protein–protein interactions showed that
FAAP20-UBZ4 has distinct binding surfaces for ubiquitin and Rev1-BRCT. In addition, the chemical
exchange patterns indicated that the interaction between FAAP20-UBZ4 and ubiquitin might
enhance the binding affinity between FAAP20-UBZ4 and Rev1-BRCT. These results provide new
insight into the Rev1 recognition mechanism by FAAP20.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction inhibiting DNA strand separation and require DNA repair forFanconi anemia (FA) is a genetic disease characterized by acute
myelogenous leukemia, bone marrow failure, and congenital
defects such as short stature and abnormalities of the skin, arms,
head, eyes, kidneys, and ears [1,2]. This disorder is caused by a
genetic defect in a group of proteins, known as FA proteins, in
charge of DNA interstrand cross-link (ICL) repair. On account of
the defect in DNA repair, cells derived from FA patients are
hypersensitive to DNA cross-linking agents, such as mitomycin C
(MMC) or diepoxybutane (DEB), and present with multiple
chromatid breaks and radial structures [3]. On the other hand, in
normal cells, DNA ICLs block transcription and replication bychromosomal stability.
The FA pathway is responsible for DNA ICL repair, and at least
16 FA proteins are involved and cooperate in this pathway. In
response to DNA damage, the FA core complex, which is composed
of at least 8 FA proteins (FANCA/B/C/E/F/G/L/M), is recruited to the
ICL region. As an E3 ligase, the FA core complex monoubiquitinates
FANCD2 and FANCI, and the monoubiquitinated FANCD2–FANCI
heterodimer recruits a nuclease for nucleolytic incision near the
ICL. Then translesion synthesis (TLS) allows the DNA replication
machinery to replicate past the DNA lesion, creating a nascent
strand for homologous recombination (HR). The double-strand
break (DSB), created by the incision process, is repaired by HR
and the remaining adducts, cross-linked nucleotides, are removed
by nucleotide excision repair (NER) [4,5].
TLS is one of several DNA repair mechanisms that tolerates
error-prone DNA repair, resulting in residual point mutations. TLS
requires specialized DNA polymerases, namely g, i, j, and Rev1
in the Y-family and polymerase f in the B-family. The TLS poly-
merases feature relatively poor processivity and low fidelity in
comparison to the regular DNA polymerases. When a regular DNA
polymerase encounters a stalled replication fork, one of the TLS
polymerases replaces it according to the type of DNA damage [6,7].
A recent study reported the regulation of TLS by FA core
complex-mediated recruitment of Rev1, suggesting that the FA
3038 K. Lim et al. / FEBS Letters 589 (2015) 3037–3043core complex, either directly or indirectly, regulates the BRCT
domain-mediated loading of Rev1 onto replication forks [8]. Fur-
thermore, Fanconi anemia-associated protein 20 (FAAP20) was
recently identified as an integral subunit of the multisubunit FA
core complex [9–12]. FAAP20 maintains the integrity of the FA core
complex through an interaction with FANCA using FAAP20’s
N-terminus (Fig. 1A). The C-terminus of FAAP20 contains a
ubiquitin-binding zinc finger 4 (UBZ4) domain (Fig. 1A), which
was identified to interact with Rev1 for promoting TLS [9].
To understand the molecular basis for FA core complex-
mediated recruitment of Rev1, we characterized the interactions
among FAAP20-UBZ4, Rev1-BRCT, and ubiquitin by nuclear mag-
netic resonance (NMR) and isothermal titration calorimetry (ITC)
experiments. In this study, we identified that FAAP20-UBZ4 inter-
act with ubiquitin and Rev1-BRCT through distinct regions and
suggested a mechanism by which FAAP20 recognizes Rev1 during
ICL repair.2. Materials and methods
2.1. Molecular cloning
The human FAAP20-UBZ4 domain (residues 103–180), FAAP20-
UBZ4 domain (residues 133–180) and Rev1-BRCT domain (residuesFig. 1. FAAP20 contains a ubiquitin-binding zinc finger 4 (UBZ4) domain in its C-term
FAAP20-UBZ4 domain (residues 144–174) with other UBZ4 domains using ESPript 3.0 [18
(N). Open boxes indicate highly similar residues greater than a similarity score’s value (
alone and in the presence of EDTA and EDTA plus Zn2+. (D) The human FAAP20 sequence
(PDB ID: 2MUQ). a = a-helix, b = b-strand. The residues coordinating Zn2+ are indicated44–132) were cloned into the modified pGEX 4T vector
(GE-Healthcare) containing an N-terminal GST tag and a tobacco
etch virus (TEV) protease site. The human ubiquitin (residues
1–76) was cloned into the pET15b vector (Novagen) containing
an N-terminal His6 tag and a thrombin protease site.
2.2. Protein expression and purification
The expression plasmids were transformed into Escherichia coli
BL21(DE3) cells. Following the addition of 200 lM ZnCl2 at 0.4
OD600, the expression of both GST-fused FAAP20-UBZ4 constructs
was induced by addition of 0.4 mM IPTG at 0.6 OD600. After 5 h fur-
ther incubation at 30 C, the harvested cells were suspended in
phosphate-buffered saline (PBS) (10 mM Na2HPO4, 140 mM NaCl,
1.8 mM KH2PO4, pH 7.5) and lysed by sonication. Cell debris was
removed by centrifugation at 15000 rpm for 1 h and the super-
natant was loaded onto a GST column (Clontech). After washing
with PBS, the protein was eluted by elution buffer (50 mM Tris–
HCl, pH 8.0, 33 mM glutathione) prepared freshly. After the protein
was cleaved with TEV protease for 16 h at 4 C, it was dialyzed
using Q-buffer (50 mM sodium phosphate, 50 mM NaCl, 2 mM
DTT, pH 6.4) and then loaded onto a Q HP column
(GE-Healthcare) automated by an AKTA machine to separate the
target protein from the GST tag and TEV protease. The peak fraction
was eluted by a 50–1000 mM linear gradient of NaCl.inus. (A) Schematic diagram of full-length FAAP20. (B) Sequence alignment of the
]. The conserved Cys and His residues are shaded in black and indicated by triangles
0.7). (C) 2D 1H, 15N-HSQC spectra of the FAAP20-UBZ4 domain (residues 103–180)
(residues 133–180) used in this study, with secondary structure elements indicated
by triangles (N).
Fig. 2. Ubiquitin binding surface of the FAAP20-UBZ4 domain characterized by NMR titration. (A) 2D 1H, 15N-HSQC spectra of the FAAP20-UBZ4 alone (in black) and in the
presence of 2 equivalents of ubiquitin (in red). (B) The equilibrium dissociation constant (Kd) between FAAP20-UBZ4 and ubiquitin was determined by ITC as described in
Section 2. ‘‘N” indicates the number of binding sites. (C) The chemical shift perturbation (CSP) is plotted against each residue of FAAP20-UBZ4. The CSP was calculated as
described in Section 2. The dashed line’s value (0.238) indicates the average CSP. (D) The residues are color coded on the structure of FAAP20-UBZ4 (in gray)/ubiquitin (in
orange) complex (PDB ID: 2MUR) by the degree of CSP: red for >0.238. The structure was visualized using PyMol (DeLano Scientific LLC, San Carlos, CA).
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with 0.4 mM IPTG for 5 h, and the protein was purified as described
above using a GST column. The protein was cleaved with TEV pro-
tease on the column for 16 h at 4 C. The protein without the GST
tag was eluted from the column by PBS and the GST tag was eluted
by elution buffer. The Rev1-BRCT mutants were prepared by
changing DNA sequences of the plasmid using site-directed
mutagenesis.
Expression of the His6-fused ubiquitin was induced at 37 C
with 0.8 mM IPTG for 5 h and was purified using a Ni-NTA column
(Qiagen). The His6 tag of ubiquitin was removed by thrombin
cleavage. Finally, the proteins were further purified by Superdex-
75 gel filtration chromatography in 25 mM sodium phosphate,
100 mM KCl, and 2 mM DTT, pH 7.0. The purity and homogeneity
of the samples were assessed using SDS–PAGE. For NMR studies,
uniform isotope labeling of proteins was obtained by growing
the cells in M9 minimal medium (6 g/L Na2HPO4, 3 g/L KH2PO4,
0.5 g/L NaCl) supplemented with 1 g/L of 15NH4Cl and 2 g/L of
13C-glucose.
2.3. NMR experiments
All experiments were carried out at 20 C on Varian 600 MHz
(KAIST) and Bruker 800 MHz spectrometers (Ochang). NMR sam-
ples were prepared in 25 mM sodium phosphate, 100 mM KCl,
2 mM DTT, and 10% D2O (pH 7.0). The following experiments were
recorded for backbone resonance assignments using 0.6–1 mM 13C,
15N-labeled proteins: 2D 1H, 15N-HSQC, 3D-HNCACB/CBCAcoNH,HNCA/HNcoCA, and HNCO/HNcaCO. In NMR titration experiments,
100–200 lM 15N-labeled proteins were prepared and 2D 1H,
15N-HSQC spectra were recorded. The weighted CSPs for backbone
1H and 15N resonances were calculated by this equation:
D ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðDHNÞ2 þ ð0:154 DNÞ2
q
. The equilibrium dissociation
constant (Kd) for the BRCT–UBZ4 complex was calculated using
the following equation [13]:
D ¼ Dmax  ðKd þ ½15N BRCT0 þ ½UBZ4Þ
n

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðKd þ ½15N BRCT0 þ ½UBZ4Þ
2  ð4 ½15N BRCT0  ½UBZ4Þ
q 
=ð2 ½15N BRCT0Þ
The weighted CSPs (D) were measured for each titration exper-
iment using the well separated residues, and the dissociation con-
stant (Kd) and value of the maximum CSP (Dmax) were extracted by
fitting the data using equation above. [15N BRCT]0 is the initial con-
centration of 15N BRCT and [UBZ4] is the concentration of UBZ4 in
each titration experiment. Spectra were processed with NMRPipe
[14] and Topspin (BrukerBioSpin) and analyzed with Sparky (T.D.
Goddard and D.G. Kneller, University of California, San Francisco).
2.4. Isothermal titration calorimetry
The equilibrium dissociation constant (Kd) for the UBZ4–ubiqui-
tin complex was determined by isothermal titration calorimetry
(ITC). The ubiquitin was titrated into a solution of FAAP20-UBZ4
3040 K. Lim et al. / FEBS Letters 589 (2015) 3037–3043in a buffer containing 25 mM sodium phosphate, 100 mM KCl, pH
7.0. Thirty injections of 10 ll each were conducted at 25 C using a
VP-ITC Microcalorimeter (MicroCal, Northampton, MA), and the
data were analyzed for one-site binding using the Origin software
(Origin Lab).
3. Results
3.1. Characterization of the FAAP20-UBZ4 domain
The C-terminus of FAAP20 was identified as a ubiquitin-binding
zinc finger domain (Fig. 1A), which is classified as a UBZ4 domain
on account of the CCHC zinc finger motif (Fig. 1B). For the initial
studies, a FAAP20-UBZ4 construct containing residues 103–180
was expressed, and the zinc coordination of the purified UBZ4
was verified by NMR titration experiments. Addition of EDTA
resulted in a dramatic narrowing of the spectrum (Fig. 1C
[middle]), suggesting that the tertiary structure of FAAP20-UBZ4
collapsed. However, addition of excess ZnCl2 recovered the disper-
sion of the peaks in the spectrum (Fig. 1C [right]), with positions
corresponding to the spectrum of 15N UBZ4 alone (Fig. 1C [left]),
indicating the reformation of original structure. These results show
that coordination of the zinc ion maintains the folding of FAAP20-
UBZ4. For subsequent studies, the construct of FAAP20 was
changed to residues 133–180 to remove the flexible regions (Fig. 1D).
3.2. Ubiquitin binding surface of the FAAP20-UBZ4 domain
characterized by NMR
The FAAP20-UBZ4 domain was previously observed to interact
with ubiquitin [10–12]. We performed NMR titration experimentsFig. 3. FAAP20-UBZ4 binding surface of the Rev1-BRCT domain characterized by NMR t
presence of 4 equivalents of FAAP20-UBZ4 (in red). (B) The chemical shift perturbation (C
indicates the average CSP. (C) The residues are color coded on the structure of Rev1-BRCT
visualized using PyMol (DeLano Scientific LLC, San Carlos, CA). (D) The equilibrium dissoc
as described in Section 2.to confirm the interaction between UBZ4 and ubiquitin and to
identify the ubiquitin binding surface on the UBZ4. Addition of
unlabeled ubiquitin into a sample of 15N-labeled UBZ4 domain
caused some peaks to gradually move in a unidirectional manner
and some peaks to gradually disappear and reappear in other posi-
tions (Fig. 2A), indicating that the binding involves the intermedi-
ate to fast exchange regime between free and ubiquitin-bound
forms on the NMR time scale. This means that the binding affinity
is in the range of lM, which was confirmed by ITC measurements.
The equilibrium dissociation constant (Kd) of the UBZ4–ubiquitin
complex was determined by ITC to be 7.57 ± 0.93 lM (Fig. 2B).
To map the ubiquitin binding site on the structure of the
FAAP20-UBZ4, various NMR experiments were recorded for back-
bone resonance assignments. The backbone resonance assign-
ments for the free FAAP20-UBZ4 are shown in Supplemental
Fig. S1. Based on the titration experiment, the CSPs were plotted
for each residue of FAAP20-UBZ4 (Fig. 2C). The residues exhibiting
perturbation above the average value of CSP were S146, C147,
M149, D164, S165, A168, C170, A172, E173, S174, E176, D177,
V178, T179 and W180, and these are mostly relevant to the inter-
mediate exchange regime (Fig. 2C). As shown in Fig. 2D, the resi-
dues with the greatest perturbations are mainly located in the b1
strand, the loop (b1–b2), the C-terminal a1 helix, and the tail of
the FAAP20-UBZ4 domain. The residues exhibiting CSP are
involved in either a direct interaction with ubiquitin or an indirect
conformational change as a result of the UBZ4’s interaction with
ubiquitin. A previous study showed that a D164A mutation in
the UBZ4 domain abolished the in vitro ubiquitin-binding activity
of FAAP20, but D162A and E173A mutations did not [10], suggest-
ing the FAAP20-UBZ4 binds ubiquitin through the exposed surface
of the a1 helix, including the residue D164. These results wereitration. (A) 2D 1H, 15N-HSQC spectra of the Rev1-BRCT alone (in black) and in the
SP) is plotted against each residue of the Rev1-BRCT. The dashed line’s value (0.007)
(PDB ID: 2EBW) (in sky blue) by the degree of CSP: red for >0.007. The structure was
iation constant (Kd) between Rev1-BRCT and FAAP20-UBZ4 was determined by NMR
K. Lim et al. / FEBS Letters 589 (2015) 3037–3043 3041precisely verified through the structure of the FAAP20-UBZ4
(residues 140–180)/ubiquitin complex, which was recently
determined by NMR spectroscopy [15].
3.3. FAAP20-UBZ4 binding surface of the Rev1-BRCT domain
characterized by NMR
The FAAP20-UBZ4 domain is known to interact with Rev1, pro-
viding a critical link between the FA pathway and TLS polymerase
activity [9]. In addition, a previous study suggested that the FA core
complex is required for restructuring stalled replication forks to
allow Rev1 loading onto DNA in a BRCT domain-dependent manner
[8]. We accordingly investigated the interaction between FAAP20-
UBZ4 and Rev1-BRCT using NMR titration. Addition of unlabeled
UBZ4 into 15N-labeled BRCT caused several peaks to gradually
move in a directional manner, but only slightly, indicating that
the binding is in the fast exchange regime on the NMR time scale
and implying weak binding (Fig. 3A). Based on the backbone reso-
nance assignments (Supplemental Fig. S2) and NMR titration
experiments, the CSP was plotted for each residue of Rev1-BRCT
(Fig. 3B). As shown in Fig. 3C, the residues perturbed above the
average value of CSP are mainly located in the loop (b2–b3) (R84
and S85) and a2 helix region (K99, I100, K101, E102, L103, K104,
G105, E106 and K107). The equilibrium dissociation constant (Kd)
of the BRCT–UBZ4 complex was determined by NMR to be
395.86 ± 93.73 lM, on average, by fitting the data to the equation
described in Section 2, using residues K104 and E106, which are
well separated and not overlaid in the NMR spectra (Fig. 3D). On
account of the very low affinity, their binding could not be con-
firmed by either pull-down assays or ITC experiments. To verify
whether the weak interaction between Rev1-BRCT and FAAP20-
UBZ4 is specific, NMR titrations of mutant constructs were
performed. Mutations were introduced into the most perturbed
residues (K104 and E106) of Rev1-BRCT and unlabeled UBZ4
was added to NMR samples of the mutants of 15N-BRCT.Fig. 4. Rev1-BRCT domain and ubiquitin bind to separate regions of the FAAP20-UBZ4 do
the absence of Rev1-BRCT (in black) and in the presence of 2 equivalents of Rev1-BRCT (
surface of FAAP20-UBZ4 bound to ubiquitin characterized by NMR titration. The BRCT
complex (PDB ID: 2MUR).15N-BRCT-K104A showed reduced CSP (data not shown), and the
15N-BRCT-K104A/E106A double mutant showed no perturbations
(Supplemental Fig. S3), indicating an abolished interaction
between BRCT and UBZ4. These surface mutations did not affect
the overall fold of the protein, as shown by the dispersed HSQC
spectra. Therefore, the interaction between Rev1-BRCT and
FAAP20-UBZ4 can be considered specific.
3.4. Binding interfaces among FAAP20-UBZ4, Rev1-BRCT and ubiquitin
Although the preceding results showed that FAAP20-UBZ4
interacts with Rev1-BRCT (Fig. 3), the CSPs of 15N-labeled UBZ4
in the presence of unlabeled BRCT included only a little chemical
shift changes in the residues in the C-terminus of UBZ4 (Supple-
mental Fig. S4). We decided to examine the effect of the interaction
between UBZ4 and ubiquitin on the BRCT binding to UBZ4. We per-
formed an NMR titration experiment, questioning whether ubiqui-
tin and BRCT compete for the interaction with UBZ4 or if the
binding surface of BRCT is separate from the ubiquitin binding site
on UBZ4. Unlabeled BRCT was titrated into a 1:2 mixture of
15N-UBZ4 and unlabeled ubiquitin. As shown in Fig. 4A and B, addi-
tion of BRCT resulted in peak broadening and CSP in some amide
resonances, indicating that BRCT can bind to the UBZ4–ubiquitin
complex and that the binding is in the intermediate to fast
exchange on the NMR time scale. Moreover, this result did not
show the peaks returning to the position of 15N-UBZ4 bound to
BRCT, implying that BRCT does not compete with ubiquitin or dis-
place it from a single binding site (Supplemental Fig. S5). To iden-
tify the residues changed during NMR titration, backbone
resonance assignment of UBZ4 bound to ubiquitin was carried
out, with assistance from assignments available in the Biological
Magnetic Resonance Bank (BMRB ID: 25230) (Supplemental
Fig. S6). To map the BRCT binding site on the structure of
FAAP20-UBZ4, we used the structure of the UBZ4/ubiquitin com-
plex (PDB ID: 2MUR), recently determined by NMR [15]. As shownmain. (A) 2D 1H, 15N-HSQC spectra of FAAP20-UBZ4 bound to unlabeled ubiquitin in
in red). (B) Expanded regions of 1H, 15N-HSQC spectra of (A). (C) Rev1-BRCT binding
binding surface is colored in red on the structure of the FAAP20-UBZ4/ubiquitin
Fig. 5. The binding surface of FAAP20-UBZ4 with ubiquitin on Rev1-BRCT domain. (A) 2D 1H, 15N-HSQC spectra of the Rev1-BRCT alone (in black) and in the presence of 2
equivalents of FAAP20-UBZ4 and ubiquitin (in red). (B) The intensity ratio (I/I0) and the chemical shift perturbation (CSP) are plotted against each residue of the Rev1-BRCT.
The intensity was evaluated as peak height of Rev1-BRCT. I and I0 are intensities in the presence and absence of FAAP20-UBZ4 and ubiquitin, respectively. Each dashed line’s
value indicates the average intensity ratio (0.642) and CSP (0.013). Open red boxes indicate significantly broadened and perturbed residues. (C) The residues are color coded
on the structure of Rev1-BRCT (PDB ID: 2EBW) by the degree of intensity ratio: red for <0.642. The structure was visualized using PyMol (DeLano Scientific LLC, San Carlos,
CA).
3042 K. Lim et al. / FEBS Letters 589 (2015) 3037–3043in Fig. 4C, the residues perturbed by BRCT titration are mainly
located in the loop (b1–b2) (M149) and the C-terminal region of
UBZ4 (S165, A168, C170, S174, E176, D177, V178 and T179). These
regions are mostly distinct from the ubiquitin binding site on UBZ4
(Fig. 4C).
Furthermore, we performed NMR titration experiments to give a
more precise binding interface between Rev1-BRCT and
FAAP20-UBZ4with ubiquitin. Addition of unlabeled UBZ4 and ubiq-
uitin into 15N-labeled BRCT caused peak broadening and CSP in
some amide resonances, indicating that the binding is in the inter-
mediate to fast exchange on the NMR time scale (Fig. 5A). Based on
the titration experiment, the intensity ratio and the CSP were plot-
ted for each residue of BRCT (Fig. 5B). The residues broadened
below the average value of the intensity ratio are mainly located
in the loop (b1–a1) (V56, N57, G58, Y59, T60 and A64), loop (b2–
b3) (H79, V80, Y81, Y82, S83, S85 and T87), b3 strand (I90 and
I91), loop (b3–a2) (T93 and L95), and a2 helix (K99, K101, E102,
L103, K104, E106 and K107) regions of BRCT. These residues signif-
icantly correspond to the residues perturbed above the average
value of the CSP. As shown in Fig. 5C, NMRmapping on the structure
of Rev1-BRCT showed the extended surfaces including the surface
perturbed by UBZ4 alone (Fig. 3C), suggesting that ubiquitin bind-
ing to UBZ4 may extend the interface between UBZ4 and BRCT,
and ubiquitin may interact with BRCT directly. So we carried out
NMR titration experiments to identify the possibility that ubiquitin
directly interacts with BRCT. First, NMR titration experiments
between BRCT and ubiquitin without UBZ4 showed that they did
not specifically interact with each other (Supplemental Fig. S7).
However, addition of unlabeled BRCT into 15N-labeled ubiquitin
bound to UBZ4 resulted in peak broadening and CSP in some amide
resonances (R42, L43, L50, E51, R72, L73, R74 and G75) (Supple-mental Figs. S8 and S9), implying that ubiquitin interact with BRCT
in the presence of UBZ4. The residues are mainly located in the
interface between ubiquitin and UBZ4, and the C-terminal tail of
ubiquitin. In addition, each BRCT binding surface on UBZ4 bound
to ubiquitin (Fig. 4C) and on ubiquitin bound to UBZ4 (Supplemen-
tal Fig. S9) is well connected each other (Supplemental Fig. S10),
suggesting that the perturbation by BRCT on ubiquitin bound to
UBZ4 may come from the interaction by the spatial proximity
between ubiquitin and BRCT through the BRCT binding to UBZ4.
5. Discussion
In this study, we characterized the interaction of FAAP20-UBZ4
with ubiquitin and Rev1-BRCT using NMR. Although the interac-
tion of UBZ4 with ubiquitin has been widely examined, the direct
interaction between UBZ4 and BRCT was first identified in this
study, showing that FAAP20-UBZ4 interacts with ubiquitin and
Rev1-BRCT through separate sites. The structure of the UBZ4/ubiq-
uitin complex showed not only that FAAP20 recognizes ubiquitin
through its canonical zinc-finger motif but also that the interaction
involves two invariant residues, D177 and W180 of UBZ4, inducing
a folding of the disordered tail in FAAP20’s C-terminus [15]. In con-
sideration of their study, we can suppose that the induced folding
of FAAP20’s C-terminus by ubiquitin might extend a possible inter-
face between UBZ4 and BRCT, and increase the binding affinity
between UBZ4 and BRCT. According to the chemical exchange in
our NMR titration experiment, the interaction between BRCT and
UBZ4 in the absence of ubiquitin showed fast exchange on the
NMR time scale, indicating lower binding affinity (Fig. 3), while
the interaction between them in the presence of ubiquitin showed
intermediate to fast exchange, indicating higher binding affinity
Fig. 6. Model for the possible interactions among FAAP20, Rev1 and ubiquitin.
Number r and s represent monoubiquitinated Rev1 and unknown ubiquitinated
protein, respectively.
K. Lim et al. / FEBS Letters 589 (2015) 3037–3043 3043(Figs. 4 and 5). Such results suggest that the binding affinity
between UBZ4 and BRCT might be improved by ubiquitin binding
to UBZ4. From these insights, we propose a recognition mechanism
in which the binding of ubiquitin to FAAP20-UBZ4 fixes the flexible
tail of UBZ4’s C-terminus, resulting in a stabilized interaction
between FAAP20-UBZ4 and Rev1-BRCT.
We also suggest possible interactions among FAAP20, Rev1 and
ubiquitin. As shown in Fig. 6, firstly, FAAP20 may bind monoubiq-
uitinated Rev1. A recent study reported that monoubiquitination of
Rev1 enhances the interaction between FAAP20 and Rev1, suggest-
ing that the ubiquitin binding motif (UBM) of Rev1 (residues
933–1041) either promotes monoubiquitination of Rev1 per se
or stabilizes the conjugated ubiquitin [9]. Interestingly, a recent
review mentioned that the Rev1 ubiquitination sites are located
near, or within, the BRCT [16]. In addition, Kim et al. also showed
that both FAAP20 wild type and the UBZ mutant coimmunoprecip-
itated with Rev1 [9], suggesting that the interaction between
FAAP20 and Rev1 can be mediated through the other interfaces
as well as the interaction of UBZ4 bound to ubiquitin with BRCT.
Secondly, FAAP20 might interact with Rev1 and another ubiquiti-
nated protein, which is unknown but likely involved in the DNA
repair process. Given the ubiquitin binding assay of FAAP20 using
polyubiquitin chains [10–12] and the structure of FAAP20-UBZ4 in
complex with K63-Ub2, which was recently determined by X-ray
crystallography [17], FAAP20-UBZ4 can also interact with a K48
or K63-linked ubiquitin chain. Through these interactions, TLS
would be regulated by the FA pathway via the FA core complex-
mediated recruitment of Rev1 to the DNA lesion.
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